coronavirus
widespread
environ
infect
human
domest
wild
mammal
bird
infect
caus
varieti
diseas
includ
bronchiti
gastroenter
hepat
enceph
symptom
rang
nearli
undetect
rapidli
fatal
combin
interact
variabl
determin
pattern
sever
coronavirusinduc
diseas
includ
infect
viru
strain
transmiss
strategi
age
immun
statu
infect
host
coronaviru
pathogenesi
best
understood
discern
variabl
dictat
clinic
outcom
chapter
focus
variabl
amongst
spike
protein
infect
viru
strain
divers
coronaviru
surfac
protein
like
contribut
epidem
diseas
import
time
topic
given
recent
emerg
human
sar
coronaviru
coronavirus
circul
natur
exhibit
consider
genet
variabl
ongo
viru
evolut
gener
novel
variant
capabl
epidem
diseas
recent
sarscov
central
goal
coronaviru
research
pinpoint
viru
strain
variat
relat
differ
epidemiolog
pathogen
potenti
identifi
variat
correl
properti
viral
transmiss
anim
human
lead
toward
mechanist
understand
epidem
also
point
relev
target
antivir
therapeut
coronavirus
clear
pronounc
variat
accommod
spike
gene
encod
corona
virion
protrus
figur
protrus
complex
oligomer
assembl
extrem
larg
amino
acid
protein
monom
integr
virion
membran
ctermin
transmembran
anchor
spike
essenti
viru
bind
cellsurfac
receptor
viruscel
membran
fusion
infect
spike
also
accumul
cell
surfac
bind
receptor
neighbor
uninfect
cell
mediat
cellcel
membran
fusion
process
creat
syncytia
caus
rapid
expans
infect
figur
thu
uniqu
characterist
protein
differ
coronaviru
isol
correl
distinct
pattern
viru
entri
viru
dissemin
via
syncytia
viru
tropism
pathogenesi
appreci
uniqu
characterist
protein
one
must
visual
activ
context
infect
cycl
begin
virion
bind
suscept
host
cell
mediat
viru
attach
cell
protein
set
apart
abil
evolv
remark
vari
attach
specif
sialic
acid
ubiquit
compon
cellsurfac
carbohydr
complex
document
lowaffin
ligand
porcin
bovin
coronaviru
spike
schultz
et
al
aminopeptidas
n
apn
type
iiorient
membran
glycoprotein
found
abund
respiratori
epithelia
receptor
antigen
group
coronavirus
delma
et
al
tresnan
et
al
member
antigen
cluster
includ
human
respiratori
virus
human
cov
well
sever
devast
anim
pathogen
transmiss
gastroenter
viru
swine
infecti
periton
viru
cat
carcinoembryon
antigenrel
cell
adhes
molecul
ceacam
immunoglobulinlik
type
iorient
membran
glycoprotein
preval
liver
gastrointestin
tract
serv
receptor
prototyp
member
antigen
group
coronaviru
mous
hepat
viru
dveksler
et
al
godfraind
et
al
receptor
group
coronavirus
includ
sever
bird
virus
caus
sever
bronchiti
chicken
turkey
current
unknown
highresolut
structur
predict
apn
sjostrom
et
al
firla
et
al
actual
known
ceacam
tan
et
al
structur
homolog
two
protein
readili
appar
thu
adapt
coronavirus
either
receptor
like
involv
substanti
remodel
bind
site
protein
regard
import
rememb
apn
ceacam
receptor
usag
correl
antigen
genet
relationship
use
divid
coronavirus
group
siddel
therefor
one
reason
infer
variat
adapt
virus
particular
receptor
usag
receptor
usag
dictat
ecolog
nich
infect
coronavirus
distinct
nich
evolv
somewhat
independ
creat
recogniz
antigen
phylogenet
group
suggest
sarscov
constitut
first
member
fourth
coronaviru
group
marra
et
al
rota
et
al
may
impli
pathogen
adapt
time
ago
bind
novel
receptor
set
apart
either
apn
ceacam
highresolut
crystallograph
structur
coronaviru
protein
yet
known
therefor
one
specul
detail
architectur
receptorbind
site
protein
moder
amen
protein
dissect
techniqu
express
fragment
assay
receptorbind
potenti
studi
roughli
local
site
receptor
interact
primari
sequenc
suzuki
taguchi
bonavia
et
al
see
figur
current
hypothes
suggest
coronavirus
diverg
type
particular
receptor
specif
amino
acid
chang
fix
protein
put
receptorbind
site
baric
et
al
may
case
howev
protein
variabl
rel
complex
mani
strain
differ
cluster
aminotermin
region
receptor
thought
bind
matsuyama
taguchi
see
figur
sever
chang
also
found
outsid
area
complex
variabl
appreci
recal
multifunct
properti
protein
contain
receptorbind
site
well
machineri
necessari
fuse
oppos
membran
figur
protein
membran
fusion
activ
constitut
except
manifest
receptor
bind
part
complex
variabl
protein
may
reflect
fact
receptorbind
membran
fusion
process
coupl
viru
entri
put
anoth
way
sreceptor
interact
releas
energi
use
creat
conform
chang
lead
sinduc
membran
fusion
coupl
receptor
bind
membran
fusion
activ
suggest
subtl
strainspecif
polymorph
virtual
anywher
larg
protein
might
affect
either
essenti
function
alter
cours
coronaviru
entri
cell
mechan
coronaviru
protein
mediat
membran
fusion
recent
clarifi
studi
bosch
et
al
involv
process
protein
respond
target
cell
receptor
bind
undergo
conform
chang
gallagh
matsuyama
taguchi
zelu
et
al
figur
next
current
unidentifi
hydrophob
portion
protein
term
fusion
peptid
fp
harpoon
target
cell
membran
figur
follow
irrevers
conform
chang
propos
mechan
smediat
membran
fusion
base
model
class
viral
fusion
attach
oligomer
spike
domain
receptor
cylind
repres
alphahel
secondari
structur
b
arrow
depict
exposur
insert
hydrophob
fusion
peptid
target
membran
subsequ
displac
cc
indic
format
alphahel
coil
coil
c
foldback
collaps
lead
membran
coalesc
domain
remov
clariti
may
fact
absent
shed
fusion
activ
see
text
format
endstag
coiledcoil
bundl
fusion
pore
subsequ
expans
pore
alphahel
portion
protein
condens
helic
bundl
figur
ultim
bring
oppos
membran
suffici
proxim
coalesc
togeth
figur
welldocu
mechan
sever
viral
cellular
protein
catalyz
membran
coalesc
weissenhorn
et
al
russel
et
al
jahn
et
al
classifi
type
fusion
reaction
algorithm
predict
secondari
protein
structur
singh
et
al
suggest
region
alpha
helic
design
heptad
repeat
hr
see
figur
coronaviru
protein
includ
sarscov
thu
gener
agre
core
fusion
machineri
coronavirus
built
way
catalyz
conserv
fusion
reaction
notabl
fusion
modul
fp
tm
span
occupi
inordin
larg
coronaviru
protein
function
relev
portion
remaind
larg
unknown
given
receptorbind
site
distant
membran
fusion
machineri
primari
structur
figur
sensibl
specul
much
protein
structur
involv
link
receptor
bind
activ
membran
fusion
crucial
coupl
control
time
locat
viru
entri
viral
protein
undergo
conform
chang
proceed
irrevers
membran
fusion
reaction
engag
cellular
receptor
embed
target
cell
membran
consid
activ
mechan
present
avail
genet
data
point
toward
noncoval
linkag
receptorbind
region
fusion
machineri
gross
siddel
matsuyama
taguchi
beststudi
mhv
system
ceacam
bind
caus
ntermin
region
separ
ctermin
integralmembran
fragment
gallagh
likelihood
reveal
fusion
apparatu
matsuyama
taguchi
process
augment
cellular
proteas
cleav
mhv
protein
site
receptorbind
fusioninduc
domain
stauber
et
al
bo
et
al
see
also
figur
proteolyt
cleavag
like
increas
overal
protein
conform
flexibl
eas
constraint
exposur
fusion
modul
allow
advanc
readili
pathway
figur
find
begin
point
toward
therapeut
target
interf
coronaviru
entri
breakthrough
like
come
detail
protein
structur
determin
consid
entir
infect
cycl
advanc
describ
intracellular
event
pertain
protein
virion
morphogenesi
state
action
protein
entri
deliv
viral
genom
cell
genom
monopartit
kb
singlestrand
positivesens
rna
lai
stohlman
organ
gene
larg
rna
well
character
mechan
gene
express
understood
detail
describ
review
see
lai
cavanagh
sawicki
sawicki
typic
rna
viru
genom
vast
major
translat
third
encod
socal
nonstructur
protein
found
virion
remain
third
encod
primarili
structur
virion
protein
figur
eclips
nonstructur
protein
synthes
without
delay
therebi
gener
rnadepend
rna
replicas
activ
subsequ
transcrib
antigenom
negativesens
rna
well
sever
subgenom
viral
mrna
essenti
virion
protein
e
envelop
matrix
n
nucleocapsid
translat
newli
creat
set
proxim
subgenom
mrna
whose
abund
infect
cell
far
greater
genom
virion
rna
therebi
permit
accumul
virion
protein
level
requir
particl
assembl
defin
characterist
coronavirion
morphogenesi
intracellular
assembl
figur
known
time
take
place
ergolgi
intermedi
compart
krijnskelock
et
al
infecti
viru
product
requir
newli
synthes
genom
rna
associ
n
protein
well
three
integralmembran
protein
e
assembl
process
describ
greater
detail
legend
figur
involv
seri
noncoval
interact
associ
de
haan
et
al
n
kuo
master
n
virion
rna
nelson
stohlman
narayanan
et
al
interestingli
assembl
secret
intracellular
vesicl
requir
e
vennema
et
al
ribonucleocapsid
dispens
must
consid
passiv
particip
particl
morphogenesi
thu
protein
depend
affin
abund
rel
may
may
engag
virion
assembl
process
model
coronaviru
infect
sm
affin
molar
ratio
portion
protein
assembl
virion
signific
proport
popul
advanc
free
protein
exocyt
pathway
infectedcel
surfac
figur
evid
coronaviru
bud
take
place
plasma
membran
locat
cellsurfac
protein
like
function
sole
mediat
cellcel
fusion
facilit
rapid
spread
infect
littl
present
known
rel
effici
sm
interact
among
coronavirus
although
interact
portion
protein
inde
differ
among
viru
strain
one
might
specul
rel
low
sm
affin
reflect
adapt
growth
condit
syncyti
spread
infect
provid
select
advantag
greater
afford
high
sm
affin
favor
effici
infect
virion
morphogenesi
known
nearli
year
gene
differ
correl
vivo
pathogen
potenti
dalziel
et
al
fleme
et
al
recent
advent
facil
revers
genet
approach
mutat
definit
link
coronaviru
virul
definit
link
requir
greater
genet
control
larg
heterogen
coronaviru
rna
genom
figur
one
could
construct
character
panel
recombin
virus
harbor
differ
gene
nowher
els
studi
pioneer
master
rottier
laboratori
yield
creativ
approach
wide
employ
manipul
genom
region
encompass
structur
gene
koetzner
et
al
kuo
et
al
process
take
advantag
fact
coronaviru
rna
tend
recombin
like
copychoic
mechan
lai
thu
defin
sitedirect
mutant
rna
deriv
vitro
transcript
recombin
endogen
viral
rna
within
infect
cell
creat
sitespecif
recombin
figur
isol
rare
recombin
far
greater
parent
nonrecombin
popul
depend
incorpor
positiveselect
marker
vitro
transcript
rna
current
approach
amount
ectodomain
strict
specif
apn
ceacam
receptor
thu
mutant
rna
encod
group
ceacamspecif
ectodomain
recombin
cell
infect
group
apnspecif
viru
desir
recombin
isol
plaqu
assay
cell
figur
subsequ
recombin
vitro
transcript
encod
group
apnspecif
ectodomain
firstgener
ceacamspecif
recombin
gener
addit
mutat
secondgener
recombin
isol
plaqu
assay
cell
remain
power
way
manipul
portion
coronaviru
genom
despit
recent
construct
fulllength
kbp
infecti
coronaviru
cdna
provid
complet
genet
control
almazan
et
al
casai
et
al
thiel
et
al
yount
et
al
rna
recombin
system
frequent
use
specif
incorpor
gene
chang
gener
find
indic
rel
subtl
alter
strongli
influenc
coronaviru
virul
tropism
sanchez
et
al
phillip
et
al
casai
et
al
tsai
et
al
correl
alter
virul
specif
receptorbind
membran
fusion
function
protein
begun
recent
find
made
perlman
laboratori
begun
establish
import
relationship
ontivero
et
al
laboratori
two
variant
group
mous
hepat
coronaviru
identifi
strike
differ
neurovirul
use
establish
revers
genet
system
rel
virul
trace
singl
amino
acid
chang
glycin
virul
isol
serin
associ
attenu
singl
differ
global
effect
overal
stabil
protein
dramat
increas
stabl
associ
concomit
stabil
membran
fusion
activ
diminish
particular
protein
could
mediat
cellcel
fusion
without
requir
ceacam
trigger
could
find
indic
subtl
mutat
outsid
core
fusion
machineri
power
influenc
smediat
fusion
instanc
affect
requir
activ
receptor
bind
find
also
point
toward
smediat
cellcel
fusion
activ
core
agent
coronaviru
pathogen
septemb
sar
sequenc
post
gene
bank
appreci
sequenc
variat
one
must
view
data
context
known
presum
sarscov
epidemiolog
viru
gener
consid
zoonot
origin
natur
wild
domest
anim
reservoir
probabl
unknown
isol
strikingli
similar
human
sarscov
isol
exot
anim
guangdong
china
guan
et
al
anim
includ
asymptomat
palm
civit
raccoon
dog
hous
singl
live
anim
market
collect
anim
cov
sequenc
show
limit
divers
nt
differ
nt
genom
specul
around
novemb
one
zoonot
sz
virus
infect
human
gener
sar
fever
dri
cough
pneumonia
viru
initi
infect
human
true
index
patient
may
never
avail
virus
isol
guangdong
patient
interest
variat
rel
sz
isol
compar
anim
sz
virus
avail
collect
human
sarscov
isol
clear
polymorph
detect
guan
et
al
see
figur
appear
rel
scatter
chang
throughout
ectodomain
regard
show
similar
collect
scatter
differ
murinespecif
laboratorygener
zoonot
form
murin
hepat
coronaviru
baric
et
al
baric
et
al
assign
xenotrop
potenti
particular
combin
mutat
challeng
import
undertak
might
accomplish
employ
approach
use
success
identifi
correl
murin
hepat
viru
virul
cdna
encod
sz
sar
isoform
well
szsar
chimera
easili
construct
use
creat
recombin
coronavirus
tropism
recombin
human
anim
cell
assess
use
tradit
virolog
method
next
challeng
correl
variat
alter
receptorbind
membran
fusion
potenti
likelihood
success
approach
rel
tradit
one
solubl
fragmentssz
sar
szsar
chimerasar
develop
mimic
authent
coronavirus
use
ligand
bind
human
anim
cell
identifi
sar
cellular
receptor
homolog
anim
cell
titrat
solubl
ligand
rel
affin
might
obtain
question
concern
whether
sar
polymorph
specif
affect
membran
fusion
reaction
address
rel
straightforward
assay
sinduc
syncytia
measur
nussbaum
et
al
among
murin
coronavirus
polymorph
effect
bind
ceacam
receptor
yet
dramat
impact
membran
fusion
krueger
et
al
import
determin
whether
similar
variabl
sar
protein
whether
membran
fusion
process
central
sarscov
speci
transfer
human
pathogen
present
clinic
use
anticoronaviru
drug
howev
target
drug
clearli
sight
one
obviou
target
coronavirusencod
proteas
essenti
posttransl
process
gene
polyprotein
function
subunit
ziebuhr
et
al
see
figur
structurebas
ration
proteas
drug
design
rel
advanc
stage
anand
et
al
proteas
inhibitor
roughli
analog
use
combat
hiv
infect
may
forthcom
second
target
one
far
relev
topic
chapter
protein
protein
caus
characterist
syncyti
cytopatholog
lung
epithelia
sar
patient
kuiken
et
al
protein
dissect
describ
link
syncyti
activ
pathogen
anim
model
investig
would
reason
focu
drug
design
block
function
therapeut
design
block
sreceptor
interact
constitut
one
strategi
recent
structur
determin
group
coronaviru
receptor
tan
et
al
delin
relev
peptid
loop
interact
protein
rao
et
al
bring
promis
hypothesi
sbind
receptor
fragment
might
construct
use
interfer
viru
entri
peptid
drug
might
block
infect
induc
prematur
trigger
fusion
reaction
figur
one
must
howev
cautiou
advoc
approach
mani
solubl
receptor
drive
protein
unproduct
denatur
state
clearli
trigger
product
fusion
reaction
matsuyama
taguchi
found
studi
hiv
solubl
moor
et
al
artho
et
al
viru
infect
may
enhanc
rather
neutral
second
strategi
might
extend
current
hypothes
concern
coronaviru
neutral
antibodi
sever
potent
neutral
monoclon
antibodi
bind
region
ceacambind
fusioninduc
domain
dalziel
et
al
mechan
neutral
far
clear
one
hypothesi
antibodi
interfer
conform
transit
link
receptor
interact
fusion
activ
highresolut
imag
antibodi
interact
could
serv
guid
construct
smaller
peptid
ligand
neutral
infect
restrict
global
conform
chang
final
recent
convinc
evid
protein
group
mous
hepat
coronaviru
carri
fusion
reaction
bosch
et
al
make
probabl
sever
coronavirus
includ
sarscov
sensit
hr
peptidebas
fusion
inhibit
peptid
deriv
hr
region
structur
similar
retrovirus
paramyxovirus
interfer
fusion
associ
complet
spike
activ
reaction
prevent
appropri
collaps
coiledcoil
bundl
wild
et
al
yao
compan
see
figur
similarli
small
peptid
repres
mous
hepat
viru
power
inhibit
viruscel
cellcel
fusion
reduc
activ
sever
log
present
concentr
bosch
et
al
peptid
block
entri
bind
transient
intermedi
conform
fusion
protein
depict
figur
c
therefor
import
know
whether
genet
variabl
inher
coronaviru
protein
alter
receptor
affin
fusion
kinet
paramet
determin
lifespan
drugsensit
intermedi
structur
reev
et
al
extens
determin
whether
peptid
effect
antivir
agent
combin
compar
studi
protein
receptor
bind
membran
fusion
investig
hr
peptidebas
antivir
activ
mechanist
understand
antivir
action
develop
lay
groundwork
requir
develop
therapi
human
anim
diseas
caus
coronavirus
